Royalty Pharma Plc: how funds voted at the meeting of 12 May 2025
- Ticker
- RPRX
- Meeting
- Season
- year to 30 June 2025
- Filers reporting
- 612
- Ballot items
- 8
612 filers on Form N-PX reported votes at the Royalty Pharma Plc meeting of 12 May 2025. The records fall into 8 ballot items. The page lists them in ballot order: items of the company first, then proposals from security holders. Each bar shows how the reporting filers split. It is not the result of the meeting.
This meeting is in the year to 30 June 2025. The latest season on file is the year to 30 June 2026. The page of Royalty Pharma Plc has the latest meeting.
If the reporting person has not received confirmation of the actual number of votes cast prior to filing a report on Form N-PX, the numbers reported may reflect the number of shares instructed to be cast. A reporting person is not required to amend a previously filed Form N-PX report if the reporting person subsequently receives confirmation of the actual number of votes cast.
The words of the SEC. Source: Form N-PX and its instructions, Special Instructions D.5 and D.8, copied on .
The words of this site: the filer writes each filing. The SEC does not say that it checked the votes. A lender does not vote shares that are on loan. A later filing (Form N-PX/A) can replace an earlier filing, and the site uses the latest.
The figures on this page count the filers that report on Form N-PX and the shares they reported. They do not count all votes cast at the meeting.
The page gives records. It gives no investment advice and no advice on how to vote.
Season on this page: year to 30 June 2025. Filings read through . How the figures are made
The ballot
Item 1: Director elections
9 nominees. 94.1% of the reported votes are for. 38 filers withheld from or voted against at least one nominee.
3,756 vote records from 178 filers. 3 of the 178 filers that marked the item voted against management.
- Positions of 40 fund families
- For 39
- Against 1
- Against management 1
Item 2: Advisory vote on executive pay (say-on-pay)
1,134 vote records from 604 filers. 142 of the 575 filers that marked the item voted against management. 29 filers gave no management mark.
- Positions of 48 fund families
- For 37
- Against 11
- Against management 11
Item 3: Advisory vote on pay tied to a merger or sale
941 vote records from 599 filers. 37 of the 570 filers that marked the item voted against management. 29 filers gave no management mark.
- Positions of 48 fund families
- For 45
- Against 3
- Against management 3
Item 4: Audit-related items (auditor ratification)
1,256 vote records from 178 filers. 1 of the 178 filers that marked the item voted against management.
- Positions of 40 fund families
- For 40
Item 5: EXTRAORDINARY TRANSACTIONS: management items
The company's items in this category are shown together, because filers word and number them differently.
413 vote records from 174 filers. 0 of the 174 filers that marked the item voted against management.
- Positions of 40 fund families
- For 40
Item 6: CAPITAL STRUCTURE: management items
The company's items in this category are shown together, because filers word and number them differently.
1,258 vote records from 177 filers. 2 of the 177 filers that marked the item voted against management.
- Positions of 40 fund families
- For 40
Item 7: COMPENSATION: management items
The company's items in this category are shown together, because filers word and number them differently.
1,225 vote records from 185 filers. 28 of the 185 filers that marked the item voted against management.
- Positions of 40 fund families
- For 31
- Against 9
- Against management 9
Item 8: CORPORATE GOVERNANCE: management items
The company's items in this category are shown together, because filers word and number them differently.
783 vote records from 175 filers. 1 of the 175 filers that marked the item voted against management.
- Positions of 40 fund families
- For 38
- Split or no vote 2
Positions of the fund families
A position is not the vote of each fund. The position of a family is the way most of the shares reported by its filers were voted. Funds of one family can vote in different ways.
KeyForAgainstAbstain or withholdSplit or no voteAgainst management
| Fund family | 2. Say-on-pay | 3. Merger pay | 4. Auditor |
|---|---|---|---|
| AllianceBernstein | For | For | For |
| Allspring | For | For | No report |
| American Century | For | Against, against management | For |
| Baird | For | For | No report |
| BlackRock and iShares | For | For | For |
| BNY Mellon | For | For | For |
| Brighthouse Funds | For | For | For |
| Capital Group and American Funds | For | For | For |
| Charles Schwab | For | For | For |
| Columbia Threadneedle | For | For | No report |
| Dimensional | Against, against management | For | For |
| DWS | For | For | No report |
| Equitable | For | For | For |
| Federated Hermes | For | For | For |
| Fidelity | For | For | For |
| First Trust | For | For | For |
| Franklin Templeton | Against, against management | For | For |
| Global X | Against, against management | For | For |
| Goldman Sachs | For | For | For |
| Guggenheim and Rydex | For | For | For |
| Harbor Funds | Against, against management | For | For |
| Invesco | For | For | For |
| J.P. Morgan | For | For | For |
| Jackson National funds | For | For | For |
| Janus Henderson | For | For | No report |
| John Hancock and Manulife | For | For | For |
| Macquarie and Delaware Funds | For | For | For |
| MassMutual | For | For | No report |
| Morgan Stanley, Eaton Vance and Calvert | For | For | For |
| Natixis and Loomis Sayles | Against, against management | For | No report |
| Neuberger Berman | Against, against management | For | No report |
| Northern Trust and FlexShares | For | For | For |
| Nuveen and TIAA | For | For | For |
| Pacific Life funds | For | For | For |
| PGIM and Prudential | Against, against management | For | For |
| PIMCO | For | For | For |
| Principal | Against, against management | For | For |
| ProShares and ProFunds | For | For | For |
| Russell Investments | Against, against management | For | For |
| SEI | Against, against management | For | For |
| State Street and SPDR | For | For | For |
| T. Rowe Price | For | Against, against management | For |
| Thrivent | For | For | For |
| Transamerica | For | For | For |
| VanEck | Against, against management | For | For |
| Vanguard | For | For | For |
| Victory Capital | For | For | For |
| Voya | For | Against, against management | For |
Questions
- How many filers reported votes at the Royalty Pharma Plc meeting?
- 612 Form N-PX filers reported votes at the meeting of 12 May 2025. On say-on-pay, 142 of 575 filers that marked the item voted against management (24.7%).
- Is this the result of the meeting?
- No. The page counts the filers that report on Form N-PX, and the shares they reported. Royalty Pharma Plc reports the result of a vote on Form 8-K.
- Why does the page show counts only for director elections?
- A director record names the nominee. This site has no page and no row about a person. For director elections it keeps the number of nominees and the split of votes.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings that list Royalty Pharma Plc with a meeting date within three days of 12 May 2025. A proposal title is the most common wording among filers. Where a wording can name a person, the SEC category is shown. The filers wrote the filings. Filings read through .